Clinical Guest Contributors

  1. FDA Provides Updated Draft Guidance To Support E6(R3) 1/27/2025

    Get a quick but thorough understanding of the latest guidance updates with this summary of "E6(R3) Good Clinical Practice: Annex 2."

  2. What Is "Patient-Centric" About A Clinical Trial? 1/24/2025

    "Patient-centric" has been a characteristic most sponsors, CROs, and sites have endeavored to achieve in describing clinical trials. But what does the term "patient centricity" actually imply?

  3. Strategizing And Implementing Your Clinical Trial Technologies 1/23/2025

    An implementation strategy will help you overcome challenges in integrating tech such as electronic clinical outcome assessments, electronic patient reported outcomes, and digital health technologies.

  4. Should We Still Be Using Trackers For Clinical Trial Management? 1/23/2025

    While excitement abounds for AI in clinical research, many professionals are still using manual trackers and logs to record data related to monitoring visits, protocol deviations, and more. TMF consultant Donatella Ballerini discusses the relevancy of tracks and logs today.

  5. Biohaven Refines Epilepsy Trial Design With Patient-Centric Focus 1/17/2025

    Medical director and clinical lead Jason T. Lerner, MD discusses Biohaven's patient-centric approach to its pediatric epilepsy clinical trials, from reducing visit frequency to offering virtual visits and more.

  6. Don't Let Poor Lab Operations Ruin Your Clinical Trial 1/15/2025

    Clinical laboratory scientist Nancy Muriithi reveals some of the most troubling issues in clinical research lab operations — and offers ways to address them.

  7. Takeda Taps AI Partner To Improve Patient Selection, Clinical Assessments, And Treatment Pathways For IBD 1/10/2025

    Takeda's Vijay Yajnik, MD, Ph.D. describes the company's partnership with an AI/ML vendor to improve endoscopic assessments in inflammatory bowel disease (IBD) research.

  8. What Does It Mean To Be "Underserved"? 1/8/2025

    Learn what makes someone "underserved," understand the importance of that person's participation in research, learn about the barriers to them doing so, and discover ways to improve their inclusion.

  9. Why Hire An Interim Chief Medical Officer? 1/6/2025

    Chief medical officers can drive substantial progress while still being cost-effective additions to a clinical team. Boyds CMO Karen Mullen, MBBS, FRCP, FFPM, GFMD discusses the value of an interim CMO.

  10. 7 Most Talked About Factors To Transform Clinical Trials 1/3/2025

    Ivanna Rosendal, global head of digitalization at Ascendis Pharma, shares the seven things guests on her podcast "Transformation in Trials" think will transform clinical trials.